|
|
Volumn 12, Issue 8, 2015, Pages 443-
|
|
Dyslipidaemia: Promising results for TA-8995 in TULIP
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANACETRAPIB;
ATORVASTATIN;
CHOLESTEROL ESTER TRANSFER PROTEIN;
CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR;
EVACETRAPIB;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
ROSUVASTATIN;
TA 8995;
UNCLASSIFIED DRUG;
FLUOROBENZENE;
HEPTANOIC ACID DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
QUINOLINE DERIVATIVE;
SULFONAMIDE;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL (TOPIC);
DRUG POTENCY;
DYSLIPIDEMIA;
HUMAN;
NOTE;
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
ANTAGONISTS AND INHIBITORS;
DYSLIPIDEMIAS;
FEMALE;
MALE;
CHOLESTEROL ESTER TRANSFER PROTEINS;
DYSLIPIDEMIAS;
FEMALE;
FLUOROBENZENES;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MALE;
PYRIMIDINES;
PYRROLES;
QUINOLINES;
SULFONAMIDES;
|
|
EID: 84938213783
PISSN: 17595002
EISSN: 17595010
Source Type: Journal
DOI: 10.1038/nrcardio.2015.97 Document Type: Note |
|
Times cited : (1)
|
|
References (1)
|
